{"id":71161,"date":"2023-06-05T13:03:41","date_gmt":"2023-06-05T11:03:41","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=71161"},"modified":"2026-02-17T16:40:10","modified_gmt":"2026-02-17T15:40:10","slug":"more-than-450-companies-adopt-veeva-vault-etmf-for-improved-trial-efficiency-and-inspection-readiness","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/more-than-450-companies-adopt-veeva-vault-etmf-for-improved-trial-efficiency-and-inspection-readiness\/","title":{"rendered":"More Than 450 Companies Adopt 勛圖惇蹋 eTMF for Improved Trial Efficiency and Inspection Readiness"},"content":{"rendered":"<p align=\"center\"><em>Companies modernizing TMF management to drive automation and speed<\/em><\/p>\n<p><strong>BARCELONA, Spain \u2014 5 June 2023<\/strong> \u2014 As the industry advances clinical operations, adopting applications on a unified platform is a top priority to increase study efficiency and compliance. More than 450 biopharma companies\u2014including 18 of the top 20 pharmas and 4 of the top 6 CROs\u2014use <a href=\"\/eu\/products\/veeva-etmf\/\">勛圖惇蹋 eTMF<\/a> to automate trial processes and improve information exchange across stakeholders.<\/p>\n<p>As regulatory and trial complexity grows, more companies are increasing transparency and inspection readiness with 勛圖惇蹋 eTMF. <a href=\"\/eu\/\">勛圖惇蹋 Systems<\/a> (NYSE: VEEV) is helping organizations address critical TMF challenges with innovations, including:<\/p>\n<ul>\n<li>TMF Bot to automate document classification for faster, more efficient processing and improved accuracy. TMF Bot has classified more than one million documents, saving customers tens of thousands of hours in processing time.\n<li><a href=\"\/eu\/products\/veeva-rim\/\">Seamless connection between 勛圖惇蹋 eTMF and 勛圖惇蹋 RIM<\/a> to increase efficiency and collaboration between clinical and regulatory teams. Customers have shared more than 40,000 documents across more than 600 studies.\n<li><a href=\"\/eu\/resources\/veeva-etmf-demo-tmf-transfer\/\">TMF Transfer<\/a> to enable the quick exchange of TMF documents between sponsors and CROs. This has eliminated hundreds of hours in manual end-of-study migrations.\n<li><a href=\"\/eu\/products\/veeva-site-connect\/\">勛圖惇蹋 Site Connect<\/a> to streamline information exchange with research sites. Customers have exchanged more than 100,000 documents across more than 1,000 connected study sites.\n<\/ul>\n<\/p>\n<p>\u201cWe\u2019re excited to continue partnering with customers to advance TMF for more efficient, compliant clinical trials,\u201d said Jason Methia, vice president, 勛圖惇蹋 Clinical Operations strategy. \u201cBy delivering 勛圖惇蹋 eTMF innovations, we\u2019re tackling challenges that can significantly streamline study processes and move the industry forward.\u201d<\/p>\n<p>勛圖惇蹋 eTMF is part of <a href=\"\/eu\/products\/veeva-clinical-platform\/\">勛圖惇蹋 Clinical Platform<\/a>, the industry\u2019s first cloud platform that unifies clinical data management and operations. 勛圖惇蹋 Clinical Platform includes 勛圖惇蹋 eTMF, <a href=\"\/eu\/products\/veeva-ctms\/\">勛圖惇蹋 CTMS<\/a>, <a href=\"\/eu\/products\/veeva-site-connect\/\">勛圖惇蹋 Site Connect<\/a>, <a href=\"\/eu\/products\/veeva-payments\/\">勛圖惇蹋 Payments<\/a>, <a href=\"\/eu\/products\/veeva-study-startup\/\">勛圖惇蹋 Study Start-up<\/a>, <a href=\"\/eu\/products\/veeva-study-training\/\">勛圖惇蹋 Study Training<\/a>, <a href=\"\/eu\/products\/veeva-edc\/\">勛圖惇蹋 EDC<\/a>, <a href=\"\/eu\/products\/veeva-cdb\/\">勛圖惇蹋 CDB<\/a>, <a href=\"https:\/\/rtsm.veeva.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">勛圖惇蹋 RTSM<\/a>, and <a href=\"\/eu\/products\/veeva-ecoa\/\">勛圖惇蹋 ePRO<\/a>. <\/p>\n<p><strong>Additional Information<\/strong><br \/>\nFor more on 勛圖惇蹋 eTMF, visit: <a href=\"\/eu\/products\/veeva-etmf\/\">veeva.com\/eu\/eTMF<\/a><br \/>\nConnect with 勛圖惇蹋 on LinkedIn: <a href=\"https:\/\/www.linkedin.com\/company\/veeva-systems\" target=\"_blank\" rel=\"noopener noreferrer\">linkedin.com\/company\/veeva-systems<\/a><\/p>\n<p><strong>About 勛圖惇蹋 Systems<\/strong><br \/>\n勛圖惇蹋 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a <a href=\"\/pbc\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Benefit Corporation<\/a>, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"\/eu\/\">veeva.com\/eu<\/a>.<\/p>\n<p><strong>勛圖惇蹋 Forward-looking Statements<\/strong><br \/>\nThis release contains forward-looking statements regarding 勛圖惇蹋\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2023, which you can find <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/0001393052\/000139305223000034\/veev-20230430.htm#i8fa5054a533a40eb9ed853f24032d7d7_124\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a> (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at <a href=\"https:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">sec.gov<\/a>.<\/p>\n<p class=\"text-center\">\n###\n<\/p>\n<p>\n<strong>Contact:<\/strong><br \/>\nJeremy Whittaker<br \/>\n勛圖惇蹋 Systems<br \/>\n+49-695-095-5486<br \/>\n<a href=\"mailto:jeremy.whittaker@veeva.com\">jeremy.whittaker@veeva.com<\/a>\n<\/p>\n<p>\n<strong>Contact:<\/strong><br \/>\nDeivis Mercado<br \/>\n勛圖惇蹋 Systems<br \/>\n925-226-8821<br \/>\n<a href=\"mailto:deivis.mercado@veeva.com\">deivis.mercado@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Companies modernizing TMF management to drive automation and speed.<\/p>\n","protected":false},"featured_media":71196,"parent":0,"template":"","class_list":["post-71161","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-clinical-operations","resource-product-20-etmf","resource-product-20-sponsor-site-collaboration","resource-product-20-vault-platform","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/71161"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/71161\/revisions"}],"predecessor-version":[{"id":71194,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/71161\/revisions\/71194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/71196"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=71161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}